Skip to main content
VANI
NASDAQ Life Sciences

Vivani's Semaglutide Implant Shows Year-Long >20% Weight Loss in Preclinical Data, Advances to Phase 1

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.07
Mkt Cap
$78.788M
52W Low
$0.905
52W High
$1.92
52W Position info
18% above low
Off High info
44% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

VANI sits 18% above its 52-week low of $0.905.

Summary

Vivani Medical announced strong preclinical results for its NPM-139 semaglutide implant, demonstrating sustained semaglutide exposure and over 20% sham-adjusted weight loss for a full year with a single administration. This significant data, coupled with the successful completion of the LIBERATE-1 first-in-human study, is advancing NPM-139 towards a Phase 1 clinical study expected to initiate in mid-2026 with results anticipated by year-end. For a clinical-stage biopharmaceutical company, these positive developments in a highly sought-after GLP-1 market are a major de-risking event and a strong positive catalyst. The company also confirmed a solid cash position, supporting operations into mid-2027 and enabling the completion of these key milestones. Investors will closely monitor the initiation and results of the upcoming Phase 1 study for NPM-139.

At the time of this announcement, VANI was trading at $1.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $78.8M. The 52-week trading range was $0.91 to $1.92. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $0.960 info
Change: -$0.2218 (-19%) info
Market Cap: $91.105M info
VANI
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $0.960 info
Change: -$0.210 (-18%) info
Market Cap: $91.105M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $0.960 info
Change: -$0.170 (-15%) info
Market Cap: $91.105M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $0.960 info
Change: -$0.380 (-28%) info
Market Cap: $91.105M info
VANI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $0.960 info
Change: -$0.440 (-31%) info
Market Cap: $91.105M info